Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Association of Atherogenic Index of Plasma With Cardiovascular Outcomes in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis Publisher Pubmed



Rabiee Rad M1 ; Ghasempour Dabaghi G1, 3 ; Darouei B2 ; Amanibeni R2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. School of Medicine, Isfahan University of Medical Science, Isfahan, Iran
  3. 3. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Cardiovascular Diabetology Published:2024


Abstract

Background: Atherogenic index of plasma (AIP) represents a novel marker in the current era of cardiovascular diseases. In this meta-analysis, we aimed to evaluate the association of AIP with cardiovascular prognosis in patients with coronary artery disease (CAD). Methods: PubMed, Scopus, and Web of Science databases were searched from inception through 2024. The primary outcome was major cardiovascular events (MACE). The secondary outcomes included all-causes death, cardiovascular death, myocardial infarction (MI), stroke, revascularization, and no-reflow phenomenon. AIP was determined by taking the logarithm of the ratio of triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C). The data analysis was represented using the risk ratio (RR) along with a 95% confidence interval (CI). Results: Sixteen studies with a total number of 20,833 patients met the eligible criteria. The pooled-analysis showed a significant increased risk of MACE in the highest AIP group compared with the lowest AIP group (RR = 1.63; 95% CI, 1.44–1.85; P < 0.001). A similar result was observed when AIP was regarded as a continuous variable (RR = 1.54; 95% CI, 1.30–1.83; P < 0.001). Besides, elevated AIP was associated with increased risk of cardiovascular death (RR = 1.79; 95% CI, 1.09–2.78; P = 0.02), MI (RR = 2.21; 95% CI, 1.55–3.13; P < 0.001), revascularization (RR = 1.62; 95% CI, 1.34–1.97; P < 0.001), no-reflow phenomenon (RR = 3.12 95% CI, 1.09–8.96; P = 0.034), and stent thrombosis (RR = 13.46; 95%CI, 1.39-129.02; P = 0.025). However, AIP was not significantly associated with the risk of all-causes death and stroke among patients with CAD. Conclusions: The results of this study demonstrated that increased AIP is an independent prognostic factors in patients with CAD. Further research is warranted to elucidate the potential development of targeted interventions to modify AIP levels and improve patient outcomes. © The Author(s) 2024.
Related Docs
View other Related Docs
1. The Predictive Value of Atherogenic Index of Plasma in the Prediction of Cardiovascular Events; a Fifteen-Year Cohort Study, Advances in Medical Sciences (2021)
2. Atherogenic Index of Plasma: A Valuable Novel Index to Distinguish Patients With Unstable Atherogenic Plaques, Journal of Research in Medical Sciences (2022)
3. Is Lp(A), As Predictor of Severity of Coronary Artery Disease?, Journal of Isfahan Medical School (2009)
4. Dietary Inflammatory Index in Relation to Severe Coronary Artery Disease in Iranian Adults, Frontiers in Nutrition (2023)
5. Comparison Between European and Iranian Cutoff Points of Triglyceride/High-Density Lipoprotein Cholesterol Concentrations in Predicting Cardiovascular Disease Outcomes, Journal of Clinical Lipidology (2016)
6. Cardiovascular Disease Risk Prediction Among Iranian Patients With Diabetes Mellitus in Isfahan Province, Iran, in 2014, by Using Framingham Risk Score, Atherosclerotic Cardiovascular Disease Risk Score, and High-Sensitive C-Reactive Protein, ARYA Atherosclerosis (2018)
7. Analysis of Traditional Risk Factors on St-Segment Elevation Myocardial Infarction Characteristics; [بررسی عوامل خطر سنتی مرتبط با ویژگیهای بالینی بیماران انفارکتوس میوکارد با بالارونده قطعه St], Journal of Isfahan Medical School (2024)
8. Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein Versus Metabolic Syndrome Criteria, Journal of Research in Health Sciences (2019)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (111)
Masoumeh Sadeghi (99)
Other Related Docs
9. Is Friedewald Formula a Good Estimation for Low Density Lipoprotein Level in Iranian Population?, Journal of Research in Medical Sciences (2012)
10. Association Between the Platelet-To-Lymphocyte Ratio and the No-Reflow Phenomenon and Thrombolysis in Myocardial Infarction Flow 3 After Primary Percutaneous Coronary Intervention in Patients With St-Segment Elevation Myocardial Infarction, Iranian Heart Journal (2017)
11. Comparing the Association of Novel Anthropometric and Atherogenicity Indices With All-Cause, Cardiovascular and Non-Cardiovascular Mortality in a General Population of Iranian Adults, American Journal of Preventive Cardiology (2025)
12. High-Sensitivity C-Reactive Protein and Low-Density Lipoprotein Cholesterol Association With Incident of Cardiovascular Events: Isfahan Cohort Study, BMC Cardiovascular Disorders (2022)
13. The Assessment of No-Reflow Phenomenon Incidence in Early Versus Delayed Percutaneous Coronary Intervention Following a Primary Fibrinolysis, ARYA Atherosclerosis (2024)
14. Prevalence of Total Cholesterol in Iran: Systematic Review and Meta-Analysis, Journal of Mazandaran University of Medical Sciences (2015)
15. Apo B Versus Cholesterol in Estimating Cardiovascular Risk and in Guiding Therapy: Report of the Thirty-Person/Ten-Country Panel, Journal of Internal Medicine (2006)
16. Fatty Acid Composition of Hdl Phospholipids and Coronary Artery Disease, Journal of Clinical Lipidology (2009)
17. The Dietary Inflammatory Index Is Positively Associated With Cardiometabolic Risk Parameters in Atherosclerosis Patients, Nutrition Research (2022)
18. Can C-Reactive Protein and Fibrinogen Predict Major Adverse Cardiac Events in Cardiovascular and Cerebrovascular Patients?, Iranian Heart Journal (2015)
19. Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity and Its Relationship to the Presence of Coronary Artery Disease, Journal of Research in Medical Sciences (2011)
20. Risk Factors for Coronary Artery Disease in Isfahan, Iran, European Journal of Public Health (1999)
21. Low-Density Lipoprotein Cholesterol and Metabolic Syndrome in an Iranian High-Risk Population, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)
22. Association of Apolipoprotein-A, B and Trans Fatty Acids With Cardiovascular Events: Isfahan Cohort Study, Journal of Isfahan Medical School (2011)
23. High Sensitivity C-Reactive Protein Predictive Value for Cardiovascular Disease: A Nested Case Control From Isfahan Cohort Study (Ics), Global Heart (2020)
24. Association of Triglyceride Glucose Index With Cardiovascular Events: Insights From the Isfahan Cohort Study (Ics), European Journal of Medical Research (2024)
25. Lipid Profile in Patients With Ischemic and Hemorrhagic Stroke, Journal of Isfahan Medical School (2011)
26. Prognostic Validation of a Non-Laboratory and a Laboratory Based Cardiovascular Disease Risk Score in Multiple Regions of the World, Heart (2018)
27. High Sensitive C-Reactive Protein Serum Levels in Patients With Acute Coronary Syndrome, Journal of Isfahan Medical School (2012)
28. Evaluation of the Relationship Between Hematological Indices and Cardiovascular Events in Isfahan Cohort Study, Avicenna Journal of Clinical Medicine (2021)
29. Which Majot Atherosclerosis’ Risk Factors Represents the Extent of Coronary Artery Disease?, Journal of Isfahan Medical School (2007)
30. Comparison of Equations for the Calculation of Ldl-Cholesterol in Familial Hypercholesterolemia: Data From Iranian Registry, Turk Kardiyoloji Dernegi Arsivi (2022)
31. Association Between Severity of Coronary Disease and Apolipoproteins a and B, Iranian Journal of Endocrinology and Metabolism (2011)
32. Utility of Serum Lipid Ratios for Predicting Incident Type 2 Diabetes: The Isfahan Diabetes Prevention Study, Diabetes/Metabolism Research and Reviews (2016)
33. 15-Year Lipid Profile Effects on Cardiovascular Events Adjusted for Cardiovascular Risk Factors: A Cohort Study From Middle-East, Acta Cardiologica (2021)
34. Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study, Review of Diabetic Studies (2016)
35. Shared Lifestyle-Related Risk Factors of Cardiovascular Disease and Cancer: Evidence for Joint Prevention, Scientific World Journal (2023)
36. Persian Registry of Cardiovascular Disease (Prove): Design and Methodology, ARYA Atherosclerosis (2017)
37. Comparison Common Equations for Ldl-C Calculation With Direct Assay and Developing a Novel Formula in Iranian Children and Adolescents: The Caspian V Study, Lipids in Health and Disease (2020)
38. Influence of Statins on Circulating Inflammatory Cytokines in Patients With Abnormal Glucose Homeostasis: A Meta-Analysis of Data From Randomized Controlled Trials, Clinical Therapeutics (2020)
39. Association of Dietary Nutrients With Blood Lipids and Blood Pressure in 18 Countries: A Cross-Sectional Analysis From the Pure Study, The Lancet Diabetes and Endocrinology (2017)
40. Proposal of a Study Protocol of a Preliminary Double-Blind Randomized Controlled Trial. Verifying Effects of Selenium Supplementation on Selenoprotein P and S Genes Expression in Protein and Mrna Levels in Subjects With Coronary Artery Disease: Selenegene Study, Acta Biomedica (2019)
41. The Association Between Hypertriglyceridemic Waist Phenotype, Menopause, and Cardiovascular Risk Factors, Archives of Iranian Medicine (2013)
42. The Association Between Glycemic Index, Glycemic Load and Total Carbohydrate Intake and Risk of Premature Coronary Artery Disease: Iran Premature Coronary Artery Disease Study (Ipad) - a Case-Control Study, Nutrition, Metabolism and Cardiovascular Diseases (2024)
43. Genetic Association With Low Concentrations of High Density Lipoprotein-Cholesterol in a Pediatric Population of the Middle East and North Africa: The Caspian-Iii Study, Atherosclerosis (2014)
44. Elevated Plasma Myeloperoxidase Levels in Relation to Circulating Inflammatory Markers in Coronary Artery Disease, Biomarkers in Medicine (2011)
45. Does Lipoprotein (A) Level Have a Predictive Value in Restenosis After Coronary Stenting?, International Journal of Preventive Medicine (2011)
46. Evaluation of Relationship Between Blood Peroxidases Activity and Visfatin Levels in Metabolic Syndrome Patients Blood Peroxidases Activity and Visfatin Levels in Metabolic Syndrome Patients, ARYA Atherosclerosis (2014)
47. The Association Between Platelet-To-Lymphocyte Ratio With Mortality Among Patients Suffering From Acute Decompensated Heart Failure, BMC Cardiovascular Disorders (2021)
48. Burden of Ischemic Heart Disease Attributable to Low Omega-3 Fatty Acids Intake in Iran: Findings From the Global Burden of Disease Study 2010, Journal of Tehran University Heart Center (2016)
49. Is Impaired Fasting Glucose Associated With Increased Risk of Coronary Aterosclerosis?, Acta Medica Iranica (2008)
50. The Pattern of In-Hospital Mortality of Myocardial Infarction and Associated Factors in Iran: A National Study, Journal of Isfahan Medical School (2015)